000			01717 a2200433 4500
005			20250514060923.0
264		0	_c20031003
008			200310s 0 0 eng d
022			_a1071-5576
024	7		_a10.1016/s1071-5576(02)00260-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aShobokshi, Amal
245	0	0	_aCorrection of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. _h[electronic resource]
260			_bJournal of the Society for Gynecologic Investigation _cFeb 2003
300			_a99-104 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aArea Under Curve
650	0	4	_aClomiphene _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEstrogen Antagonists _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollicle Stimulating Hormone _xblood
650	0	4	_aHumans
650	0	4	_aHyperandrogenism _xcomplications
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin Resistance
650	0	4	_aInsulin-Like Growth Factor Binding Protein 3 _xblood
650	0	4	_aInsulin-Like Growth Factor I _xdrug effects
650	0	4	_aLuteinizing Hormone _xblood
650	0	4	_aMenstruation
650	0	4	_aPolycystic Ovary Syndrome _xcomplications
650	0	4	_aRosiglitazone
650	0	4	_aThiazoles _xtherapeutic use
650	0	4	_aThiazolidinediones
700	1		_aShaarawy, Mohamed
773	0		_tJournal of the Society for Gynecologic Investigation _gvol. 10 _gno. 2 _gp. 99-104
856	4	0	_uhttps://doi.org/10.1016/s1071-5576(02)00260-5 _zAvailable from publisher's website
999			_c12391032 _d12391032